logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
M

Multiple Sclerosis Journal – Experimental, Translational and Clinical

IF
Papers44
Citations
Journal Papers 43
Publication Date
delete
Assessment of the impact of outcome definitions on power in multiple sclerosis clinical trials
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-04-01
delete0
PREAI
deleteCynthia X Li; Bonnie I Glanz; Moogeh Baharnoori; Brian C Healy
deleteShare
deleteSave
Clinical relevance and predictors of anti-natalizumab antibodies in multiple sclerosis: A real-world retrospective cohort study
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-03-30
delete0
PREAI
deleteMichael Levy; Ysoline Beigneux; Thomas Roux; Mathieu Mossad; Vito Ricigliano; Marie Senant; Caroline Papeix; Bruno Stankoff; Celine Louapre; Elisabeth Maillart; Andrea Lazzarotto
deleteShare
deleteSave
Characteristics of myelin oligodendrocyte glycoprotein antibody-associated meningoencephalitis
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-03-26
delete0
PREAI
deleteAisha Elfasi; Samir Alkabie; Elsa Rodriguez; Mayra Montalvo; Rhaisa Castrodad-Molina; Fernando X Cuascut; George J Hutton; Revere Kinkel; Jennifer Graves; Torge Rempe
deleteShare
deleteSave
The interconnection of multiple sclerosis and neurofibromatosis type 1: A single institution retrospective study and systematic review
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-03-26
delete0
PREAI
deleteDanielle A Bazer; Grace E Tobin; Nyah Woller-Li; Marcus Spann; Carlos G Romo
deleteShare
deleteSave
Safety and efficacy of extended versus standard interval dosing of anti-CD20 therapy in multiple sclerosis – A meta-analysis
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-03-24
delete0
PREAI
deleteMahmoud Elkhooly; Rhea Jacob; Torge Rempe
deleteShare
deleteSave
Rescue cyclophosphamide for severe multiple sclerosis relapses
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-03-18
delete0
PREAI
deleteVlad C Bibic; Robert Carruthers; Daniel Hong; Donna Kuipers; Karen Tulloch; Virginia Devonshire; Alice Schabas
deleteShare
deleteSave
Use of optical coherence tomography in the care of people with multiple sclerosis in Switzerland: A national survey among neurologists
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-02-23
delete0
PREAI
deleteVeronika Kana; Marina Herwerth; Konstantin Gugleta; Raphaël Bernard-Valnet; Stefanie Mueller; Giulia Mallucci; Fabienne C Fierz; Cristina Granziera; Jens Kuhle; Patrick Roth; Athina Papadopoulou
deleteShare
deleteSave
Real-world safety and effectiveness of ofatumumab in multiple sclerosis: A clinic-based study in Australia
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-02-23
delete0
PREAI
deleteTurlough Montague; Emily Cheung; Yuuki Kang; Venkatesha Venkatesha; Katherine Zeme; Spencer Ferrier; Karen Thomas; Nicole Simpson-Burke; Celia Miller; Sophie Chatterton; Ariadna Fontes Villalba; John Parratt
deleteShare
deleteSave
In multiple sclerosis, cognitive disengagement syndrome (CDS) is associated with higher depression, insomnia, fatigue, and paresthesia
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-02-15
delete0
deleteOAAI
deleteDena Sadeghi-Bahmani; G. Leornard Burns; Atefeh Meghrazi; Mohammad Hossein Abdollah; Annette B. Brühl; Serge Brand; Stephen P Becker
deleteShare
deleteSave
Diagnostic pathways and barriers in multiple sclerosis in Zambia: A qualitative study
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-02-11
delete0
deleteOAAI
deleteMashina Chomba; Dominique Mortel; Sarah Braun; Malya Sahu; Deanna Saylor
deleteShare
deleteSave
Baricitinib triggering a central nervous system inflammatory-demyelinating disease: A case report
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-02-02
delete0
PREAI
deleteRozita Khalili; Ahmad A. Toubasi; Meryim Poursheykhi; Francesca Bagnato
deleteShare
deleteSave
Apolipoprotein E4 and its later-life health effects on the multiple sclerosis population
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-27
delete0
deleteOAAI
deleteDean Zeldich; Chia Hsin Cheng; Yi Guan; Sriman Narain; Bang-Bon Koo
deleteShare
deleteSave
The impact of relapse on patient disability, clinical outcomes, and subsequent burdens to patients with neuromyelitis optica spectrum disorder and caregivers
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-23
delete0
deleteOAAI
deleteSaif Huda; Martin Kleman; Karl-Johan Myren; Mia Unsworth; Giorgio Castellano; Banu Kilic Taskopru; Kristie Fitzmaurice
deleteShare
deleteSave
Setting priorities for how future research in multiple sclerosis in Canada considers equity, diversity and inclusion: A modified e-Delphi study
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-20
delete0
PREAI
deleteRuth Ann Marrie; Afolasade Fakolade; Colleen J Maxwell; Dalia L Rotstein; Helen Tremlett; E. Ann Yeh; Marcia Finlayson
deleteShare
deleteSave
Leptomeningeal enhancement in multiple sclerosis demonstrates posterior predilection and T 1 alterations in the adjacent cortex
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-20
delete0
PREAI
deleteAshley A. Thommana; Erin S. Beck; Matthew A. Greenwald; Gina Norato; Hallie Gaitsch; Dzung L. Pham; Steven Jacobson; María I. Gaitán; Govind Nair; Daniel S. Reich; Serhat V. Okar
deleteShare
deleteSave
Comorbidities in newly diagnosed multiple sclerosis patients: A population-based register study in Finland
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-14
delete0
PREAI
deleteHenrik Ahvenjärvi; Johanna Krüger; Matias Viitala; Elina Jokinen; Henri Autio; Anne M Portaankorva; Merja Soilu-Hänninen; Mervi Ryytty
deleteShare
deleteSave
Association of treatment decision with personality, coping strategies and impulsivity in patients with multiple sclerosis
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-13
delete0
deleteOAAI
deleteJan Philipp Nolte; Fabian Föttinger; Nik Krajnc; Markus Ponleitner; Fritz Leutmezer; Tobias Monschein; Paulus S Rommer; Christiane Schmied; Barbara Kornek; Tobias Zrzavy; Gudrun Zulehner; Thomas Berger; Gabriel Bsteh
deleteShare
deleteSave
T lymphopenia in multiple sclerosis patients treated with ofatumumab: Even with consideration for CD3  +  CD20 + cells
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2026-01-02
delete0
deleteOAAI
deleteMasami Tanaka; Masako Kinoshita; Keiko Tanaka
deleteShare
deleteSave
Multiple sclerosis relapse risk factors across treatment eras
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2025-12-22
delete0
deleteOAAI
deleteEvan Madill; Brian Healy; Mariann Polgar-Turcsanyi; Tanuja Chitnis
deleteShare
deleteSave
How do neurologists perceive the organization and functioning of multiple sclerosis care units?
deleteMultiple Sclerosis Journal – Experimental, Translational and Clinical
IF0
delete2025-12-12
delete0
deleteOAAI
deleteLamberto Landete; Rocío Gómez-Ballesteros; Virginia Meca-Lallana; Ana B Caminero; Jose E Meca-Lallana; Sergio Martínez-Yélamos; Jose M García-Domínguez; Eduardo Agüera; Elena García-Arcelay; Nicolas Medrano; Luisa M Villar; Enric Monreal; Jorge Maurino
deleteShare
deleteSave